T/CACM 1315-2019 Active Group standards

T/CACM 1315-2019 Chinese Internal Medicine Clinical Guidelines for the Diagnosis and Treatment of Alzheimer's Disease

T/CACM 1315-2019 Chinese Internal Medicine Clinical Guidelines for the Diagnosis and Treatment of Alzheimer's Disease

Publish Date: 2019-01-30 Implement Date: 2020-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CACM 1315-2019
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Medicine
ICS Name: Comprehensive Pharmaceutical Science
Publish Date: 2019-01-30
Implement Date: 2020-01-01

Scope

Main technical content: This guideline provides recommendations for the diagnosis, differential diagnosis, treatment, prevention, and care of Alzheimer's disease. This guideline is applicable to the diagnosis and prevention of Alzheimer's disease in people over the age of 40. This guideline is suitable for clinicians in geriatrics, neurology, and traditional Chinese medicine departments of general hospitals, etc.

Development Information

Related Standards

Contact Us